s6y

CARACO PHARMACEUTICAL LABORATORIES LTD

CIK
887708
Industry
Pharmaceutical Preparations

Financials 31

  1. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Mar 31, 2011
  2. 10-Q Quarterly Report for period ending Dec 31, 2010
  3. 10-Q Quarterly Report for period ending Sep 30, 2010
  4. 10-Q Quarterly Report for period ending Jun 30, 2010
  5. 10-K Annual Report for period ending Mar 31, 2010
  6. 10-Q Quarterly Report for period ending Dec 31, 2009
  7. 10-Q Quarterly Report for period ending Sep 30, 2009
  8. 10-Q Quarterly Report for period ending Jun 30, 2009
  9. 10-K Annual Report for period ending Mar 31, 2009
  10. 10-Q Quarterly Report for period ending Dec 31, 2008

All 31 financials filings

News 98

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 98 news filings

Ownership 174

  1. 3 Initial statement of beneficial ownership of securities
  2. 4/A Statement of changes in beneficial ownership of securities
  3. 4/A Statement of changes in beneficial ownership of securities
  4. 4/A Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 174 ownership filings

Prospectus 6

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  5. RW Registration Withdrawal Request
  6. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Proxies 25

  1. DEFM14A Definitive proxy statement relating to a merger, acquisition, or disposition
  2. PRER14A Preliminary revised proxy soliciting materials
  3. PRER14A Preliminary revised proxy soliciting materials
  4. PREM14A Preliminary proxy statement relating to a merger, acquisition, or disposition
  5. DEF 14A Definitive proxy statements
  6. DEF 14A Definitive proxy statements
  7. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  8. DEFR14A Definitive revised proxy soliciting materials
  9. DEF 14A Definitive proxy statements
  10. DEF 14A Definitive proxy statements

All 25 proxies filings

Other 83

  1. CT ORDER Order Granting Confidential Treatment
  2. 15-12B Notice of termination of registration of a class of securities under Section 12(b)
  3. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  4. CT ORDER Order Granting Confidential Treatment
  5. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  6. UPLOAD Letter (PDF)
  7. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  8. UPLOAD Letter (PDF)
  9. CT ORDER Order Granting Confidential Treatment
  10. ARS Annual report to security holders

All 83 other filings